Hyunwoo Chung1,2,3, Hyun-Je Kim1,2,3, Jung-Sik Kim1, Il-Hee Yoon4, Byoung-Hoon Min1, Jun-Seop Shin1, Jong-Min Kim1,5,6, Won-Woo Lee1,2,3,5, Chung-Gyu Park1,2,3,5,6,7. 1. Seoul National University College of Medicine, Xenotransplantation Research Center, Seoul, Korea. 2. Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Korea. 3. Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea. 4. VHS Veterans Medical Research Institute, VHS Medical Center, Seoul, Korea. 5. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. 6. Institute of Endemic Diseases, Seoul National University College of Medicine, Seoul, Korea. 7. Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
Abstract
BACKGROUND: Xenogeneic islet transplantation using porcine pancreata has been a promising option for substituting human islet transplantation. Moreover, recent advances in pre-clinical results have put islet xenotransplantation closer to the possibility of clinical application. While preparing for the era of clinical xenotransplantation, developing non-invasive immune monitoring method which could predict the graft fate could benefit the patient. However, there are few reports showing predictive immune parameters associated with the fate of the graft in islet xenotransplantation. METHODS: The absolute number and ratio of T-cell subsets have been measured via flow cytometry from the peripheral blood of 16 rhesus monkeys before and after porcine islet xenotransplantation. The correlation between the graft survival and the absolute number or ratio of T cells was retrospectively analyzed. RESULTS: The ratio of CD4+ versus CD8+ T cells was significantly reduced due to CD8+ effector memory cells' increase. Correlation analyses revealed that CD4+ /CD8+ , CD4+ /CD8+ naïve, CD4+ naïve/CD8+ naïve, and CD4+ central memory/CD8+ naïve cell ratios negatively correlated with the duration of graft survival. Conversely, further analyses discovered strong, positive correlation of CD4+ /CD8+ cell ratios within the early graft-rejected monkeys (≤60 days). CONCLUSIONS: This retrospective study demonstrated that CD4+ /CD8+ ratios correlated with graft survival, especially in recipients which rejected the graft in early post-transplantation periods. CD4+ /CD8+ ratios could be used as a surrogate marker to predict the graft fate in pig-to-NHP islet xenotransplantation.
BACKGROUND: Xenogeneic islet transplantation using porcine pancreata has been a promising option for substituting human islet transplantation. Moreover, recent advances in pre-clinical results have put islet xenotransplantation closer to the possibility of clinical application. While preparing for the era of clinical xenotransplantation, developing non-invasive immune monitoring method which could predict the graft fate could benefit the patient. However, there are few reports showing predictive immune parameters associated with the fate of the graft in islet xenotransplantation. METHODS: The absolute number and ratio of T-cell subsets have been measured via flow cytometry from the peripheral blood of 16 rhesus monkeys before and after porcine islet xenotransplantation. The correlation between the graft survival and the absolute number or ratio of T cells was retrospectively analyzed. RESULTS: The ratio of CD4+ versus CD8+ T cells was significantly reduced due to CD8+ effector memory cells' increase. Correlation analyses revealed that CD4+ /CD8+ , CD4+ /CD8+ naïve, CD4+ naïve/CD8+ naïve, and CD4+ central memory/CD8+ naïve cell ratios negatively correlated with the duration of graft survival. Conversely, further analyses discovered strong, positive correlation of CD4+ /CD8+ cell ratios within the early graft-rejected monkeys (≤60 days). CONCLUSIONS: This retrospective study demonstrated that CD4+ /CD8+ ratios correlated with graft survival, especially in recipients which rejected the graft in early post-transplantation periods. CD4+ /CD8+ ratios could be used as a surrogate marker to predict the graft fate in pig-to-NHP islet xenotransplantation.
Authors: Idelberto R Badell; Maria C Russell; Peter W Thompson; Alexandra P Turner; Tim A Weaver; Jennifer M Robertson; Jose G Avila; Jose A Cano; Brandi E Johnson; Mingqing Song; Frank V Leopardi; Sarah Swygert; Elizabeth A Strobert; Mandy L Ford; Allan D Kirk; Christian P Larsen Journal: J Clin Invest Date: 2010-11-22 Impact factor: 14.808
Authors: A M James Shapiro; Camillo Ricordi; Bernhard J Hering; Hugh Auchincloss; Robert Lindblad; R Paul Robertson; Antonio Secchi; Mathias D Brendel; Thierry Berney; Daniel C Brennan; Enrico Cagliero; Rodolfo Alejandro; Edmond A Ryan; Barbara DiMercurio; Philippe Morel; Kenneth S Polonsky; Jo-Anna Reems; Reinhard G Bretzel; Federico Bertuzzi; Tatiana Froud; Raja Kandaswamy; David E R Sutherland; George Eisenbarth; Miriam Segal; Jutta Preiksaitis; Gregory S Korbutt; Franca B Barton; Lisa Viviano; Vicki Seyfert-Margolis; Jeffrey Bluestone; Jonathan R T Lakey Journal: N Engl J Med Date: 2006-09-28 Impact factor: 91.245
Authors: Martin Guimond; Rachelle G Veenstra; David J Grindler; Hua Zhang; Yongzhi Cui; Ryan D Murphy; Su Young Kim; Risu Na; Lothar Hennighausen; Sema Kurtulus; Batu Erman; Polly Matzinger; Melinda S Merchant; Crystal L Mackall Journal: Nat Immunol Date: 2009-01-11 Impact factor: 25.606
Authors: Abhijit Jagdale; Huy Nguyen; Hayato Iwase; Jeremy B Foote; Takayuki Yamamoto; Mariyam Javed; David Ayares; Douglas J Anderson; Devin E Eckhoff; David K C Cooper; Hidetaka Hara Journal: Transpl Immunol Date: 2022-01-31 Impact factor: 2.032